 | |
| Formerly | J.F. Macfarlan Ltd (1780–1829) J.F. Macfarlan and Co Ltd. (1830–1961) Edinburgh Pharmaceutical Industries (1962) Macfarlan Smith Ltd (1963–1989) Meconic (1990–2000) Johnson Matthey Health (2001–2022) |
|---|---|
| Company type | Limited Partnership |
| Industry | Contract development and manufacturing organization (CDMO) |
| Headquarters | 435 Devon Park Drive, Suite 400, Wayne, PA. 19807 |
Area served | Worldwide |
Key people | Mike Riley (CEO) |
| Website | https://veranova.com/ |
Veranova, L.P. (formally Johnson Matthey Health) is an American multinational contract development and manufacturing organization (CDMO) based in Wayne, PA, with operations in North America and Europe.[1]
The company focuses on the process, development, and manufacturing of active pharmaceutical ingredients (APIs), particularly specialty and highly regulated, complex chemistries.[2] It has two divisions, Generics and Originators. Its specialized drug development and manufacturing technologies and expertise in the pharmaceutical and biotechnology industries span the drug development lifecycle.[1][3]
Johnson Matthey Health was purchased in 2022 by Altaris Capital Partners for £325 million (JM retaining 30% equity) and rebranded to become Veranova; the name originates from the combined Latin words ‘vērus’, meaning ‘true’, and ‘nŏvus’, meaning ‘new’.[3][4]
- ^ a b "Veranova L.P." CPHI Online. Retrieved 2024-07-02.
{{cite web}}: CS1 maint: url-status (link) - ^ "Veranova: Leading the Way in Synthetic Chemistry". The Medicine Maker. 2022-09-06. Retrieved 2024-07-02.
- ^ a b "Johnson Matthey Health Rebrands as Veranova". PharmTech. 2022-06-09. Retrieved 2024-07-02.
- ^ "Johnson Matthey completion of Health sale – Company Announcement - FT.com". markets.ft.com. Retrieved 2024-07-02.
© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search